Anna Bornefalk‐Hermansson

Safety of benzodiazepines and opioids in very severe respiratory disease: national prospective study

Magnus Ekström, Anna Bornefalk‐Hermansson, Amy P. Abernethy et al. · BMJ · 2014 · 295 citations · Full text

Ciprofloxacin for 7 days versus 14 days in women with acute pyelonephritis: a randomised, open-label and double-blind, placebo-controlled, non-inferiority trial

Torsten Sandberg, Gunilla Skoog, Anna Bornefalk‐Hermansson et al. · The Lancet · 2012 · 185 citations

Urology, Antibiotics, Antimicrobial Stewardship +4

Effects of Cardiovascular Drugs on Mortality in Severe Chronic Obstructive Pulmonary Disease

Magnus Ekström, Anna Bornefalk‐Hermansson, Kerstin Ström · American Journal of Respiratory and Critical Care Medicine · 2013 · 155 citations

Hypo- and hypercapnia predict mortality in oxygen-dependent chronic obstructive pulmonary disease: a population-based prospective study

Zainab Ahmadi, Anna Bornefalk‐Hermansson, Karl A. Franklin et al. · Respiratory Research · 2014 · 72 citations · Full text

The identification of complex interactions in epidemiology and toxicology: a simulation study of boosted regression trees

Erik Lampa, Lars Lind, Peter Lind et al. · Environmental Health · 2014 · 58 citations · Full text